CRISPR Therapeutics AG
CRSP
37 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Oct 16 9:45 PM | Simeon GeorgeDirector | Sale | 14,514 | $49.63 | $720.4K | 15,486(D) | View → |
| Oct 14, 2026 | Oct 15 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 1,040 | $49.26 | $51.2K | 95,857(D) | View → |
| Oct 14, 2026 | Oct 15 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 4,098 | $49.26 | $201.9K | 259,736(D) | View → |
| Oct 14, 2026 | Oct 14 8:16 PM | SIMEON GEORGE | Proposed Sale | 14,514 | $49.63 | $720.4K | — | View → |
| Oct 6, 2026 | Oct 8 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 1,990 | $60.04 | $119.5K | 94,784(D) | View → |
| Oct 6, 2026 | Oct 6 8:47 PM | JAMES KASINGER | Proposed Sale | 1,990 | $60.04 | $119.5K | — | View → |
| Sep 22, 2026 | Sep 24 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 10,400 | $60.24 | $626.5K | 94,784(D) | View → |
| Sep 22, 2026 | Sep 22 8:42 PM | JAMES KASINGER | Proposed Sale | 10,400 | $60.24 | $626.5K | — | View → |
| Sep 17, 2026 | Sep 21 10:40 PM | Ali BehbahaniDirector | Sale | 13,679 | $57.09 | $780.9K | 16,637(D) | View → |
| Sep 17, 2026 | Sep 17 8:08 PM | ALI BEHBAHANI | Proposed Sale | 13,679 | $57.09 | $780.9K | — | View → |
| May 29, 2026 | Jun 1 9:35 PM | Naimish PatelChief Medical Officer | Sale | 3,786 | $55.62 | $210.6K | 19,357(D) | View → |
| Mar 23, 2026 | Mar 24 9:38 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 3,182 | $46.78 | $148.9K | 94,308(D) | View → |
| Mar 23, 2026 | Mar 24 9:37 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 10,020 | $46.78 | $468.7K | 255,501(D) | View → |
| Mar 23, 2026 | Mar 24 9:37 PM | Raju PrasadChief Financial Officer | Sale | 3,708 | $46.78 | $173.5K | 15,565(D) | View → |
| Mar 16, 2026 | Mar 17 9:37 PM | Naimish PatelChief Medical Officer | Sale | 3,150 | $48.26 | $152.0K | 13,143(D) | View → |
| Mar 16, 2026 | Mar 17 9:37 PM | Raju PrasadChief Financial Officer | Sale | 9,869 | $48.26 | $476.3K | 13,773(D) | View → |
| Mar 16, 2026 | Mar 17 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 3,450 | $48.26 | $166.5K | 91,240(D) | View → |
| Mar 16, 2026 | Mar 17 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 10,349 | $48.26 | $499.4K | 245,834(D) | View → |
| Mar 11, 2026 | Mar 12 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Sale | 2,800 | $52.80 | $147.8K | 87,815(D) | View → |
| Mar 11, 2026 | Mar 12 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Sale | 9,798 | $52.80 | $517.3K | 235,558(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Mar 24 9:38 PM | James R. KasingerGeneral Counsel and Secretary | Option Exercise | 6,250 | — | 12,000(D) | View → |
| Mar 20, 2026 | Mar 24 9:38 PM | James R. KasingerGeneral Counsel and Secretary | Grant/Award | 63,499 | $46.24 | 25,000(D) | View → |
| Mar 20, 2026 | Mar 24 9:37 PM | Samarth KulkarniDirector, Chief Executive Officer | Grant/Award | 196,124 | $46.24 | 81,875(D) | View → |
| Mar 20, 2026 | Mar 24 9:37 PM | Samarth KulkarniDirector, Chief Executive Officer | Option Exercise | 19,687 | — | 39,375(D) | View → |
| Mar 20, 2026 | Mar 24 9:37 PM | Raju PrasadChief Financial Officer | Option Exercise | 6,250 | — | 12,500(D) | View → |
| Mar 20, 2026 | Mar 24 9:37 PM | Raju PrasadChief Financial Officer | Grant/Award | 65,999 | $46.24 | 27,500(D) | View → |
| Mar 20, 2026 | Mar 24 9:36 PM | Naimish PatelChief Medical Officer | Grant/Award | 68,499 | $46.24 | 30,000(D) | View → |
| Mar 14, 2026 | Mar 17 9:37 PM | Naimish PatelChief Medical Officer | Option Exercise | 8,125 | — | 24,375(D) | View → |
| Mar 14, 2026 | Mar 17 9:37 PM | Raju PrasadChief Financial Officer | Option Exercise | 16,875 | — | 20,625(D) | View → |
| Mar 14, 2026 | Mar 17 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Option Exercise | 6,875 | — | 20,625(D) | View → |
| Mar 14, 2026 | Mar 17 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Option Exercise | 20,625 | — | 61,875(D) | View → |
| Mar 10, 2026 | Mar 12 9:35 PM | James R. KasingerGeneral Counsel and Secretary | Option Exercise | 5,500 | — | 5,500(D) | View → |
| Mar 10, 2026 | Mar 12 9:35 PM | Samarth KulkarniDirector, Chief Executive Officer | Option Exercise | 19,250 | — | 19,250(D) | View → |
| Feb 18, 2026 | Feb 20 10:36 PM | Samarth KulkarniDirector, Chief Executive Officer | Option Exercise | 13,250 | — | 0(D) | View → |
| Feb 18, 2026 | Feb 20 10:35 PM | James R. KasingerGeneral Counsel and Secretary | Option Exercise | 3,825 | — | 0(D) | View → |
| Jan 22, 2026 | Jan 26 10:35 PM | Raju PrasadChief Financial Officer | Option Exercise | 34,972 | $45.15 | 41,667(D) | View → |
← Previous
Page 2 of 2